| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.94B | 1.84B | 2.04B | 2.48B | 967.43M |
| Gross Profit | 377.94M | 358.07M | 355.21M | 294.97M | 177.25M |
| EBITDA | 153.20M | 142.13M | 131.35M | 106.03M | 70.26M |
| Net Income | 80.67M | 76.10M | 71.04M | 68.43M | 35.47M |
Balance Sheet | |||||
| Total Assets | 799.20M | 736.39M | 651.39M | 794.74M | 465.79M |
| Cash, Cash Equivalents and Short-Term Investments | 91.45M | 79.02M | 57.83M | 193.80M | 29.65M |
| Total Debt | 234.52M | 194.88M | 180.33M | 90.38M | 99.98M |
| Total Liabilities | 532.43M | 484.88M | 418.76M | 564.03M | 260.21M |
| Stockholders Equity | 266.77M | 251.51M | 232.63M | 230.71M | 206.48M |
Cash Flow | |||||
| Free Cash Flow | 106.62M | 91.58M | -144.98M | 221.11M | 38.86M |
| Operating Cash Flow | 107.07M | 108.75M | -132.49M | 232.13M | 48.80M |
| Investing Cash Flow | -63.49M | -26.08M | -8.15M | -11.52M | -8.38M |
| Financing Cash Flow | -31.15M | -61.48M | 4.66M | -57.16M | -35.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £287.73M | 10.78 | 31.43% | 4.14% | 8.51% | 7.04% | |
70 Outperform | £137.88M | 12.75 | 4.19% | 4.38% | 3.31% | -8.63% | |
69 Neutral | £2.54B | 28.00 | 3.94% | 2.78% | -11.94% | -84.94% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
63 Neutral | £614.15M | 7.60 | 27.40% | 7.01% | 5.60% | 4.97% | |
59 Neutral | £7.93B | 13.02 | 1.68% | 2.86% | -2.11% | -104.48% | |
56 Neutral | £29.18B | 23.74 | 9.45% | 2.98% | 0.54% | -2.65% |